SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
____________________________________
SCHEDULE 13G
Information Statement pursuant to
Rule 13d-1 and 13d-2
____________________________________
Spectrum Pharmaceuticals
------------------------
(Name of Issuer)
COMMON STOCK ($0.01 par value)
------------------------------
(Title of Class of Securities)
640656104
---------
(CUSIP Number)
January 16, 2003
(Date of event which requires filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[ X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
(Continued on following pages)
(Page 1 of 16 Pages)
Page 2 of 16 Pages
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Omicron Master Trust
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP (a) [ ]
(b) [ ] (See Item 6)
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION: Bermuda
--------------------------------------------------------------------------------
5. SOLE VOTING POWER
NUMBER OF SHARES None.
BENEFICIALLY OWNED BY 6. SHARED VOTING POWER
EACH 250,701 shares of Common Stock of the Issuer (see Item 4(a))
REPORTING 7. SOLE DISPOSITIVE POWER
PERSON WITH None.
8. SHARED DISPOSITIVE POWER
250,701 shares of Common Stock of the Issuer (see Item 4(a))
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
250,701 shares of Common Stock of the Issuer (see Item 4(a))
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES [ ]
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
8.5% (See Item 4(a))
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON
PN
--------------------------------------------------------------------------------
Page 3 of 16 Pages
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Omicron Capital, L.P.
52-2057093
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP (a) [ ]
(b) [ ] (See Item 6)
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION: Delaware
--------------------------------------------------------------------------------
5. SOLE VOTING POWER
NUMBER OF SHARES None.
BENEFICIALLY OWNED BY 6. SHARED VOTING POWER
EACH None.
REPORTING 7. SOLE DISPOSITIVE POWER
PERSON WITH None.
8. SHARED DISPOSITIVE POWER
250,701 shares of Common Stock of the Issuer (see Item 4(a))
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
250,701 shares of Common Stock of the Issuer (see Item 4(a))
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES [ ]
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
8.5% (See Item 4(a))
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON
PN
--------------------------------------------------------------------------------
Page 4 of 16 Pages
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Omicron Capital, Inc.
52-2032702
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP (a) [ ]
(b) [ ] (See Item 6)
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION: Delaware
--------------------------------------------------------------------------------
5. SOLE VOTING POWER
NUMBER OF SHARES None.
BENEFICIALLY OWNED BY 6. SHARED VOTING POWER
EACH None.
REPORTING 7. SOLE DISPOSITIVE POWER
PERSON WITH None.
8. SHARED DISPOSITIVE POWER
250,701 shares of Common Stock of the Issuer (see Item 4(a))
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
250,701 shares of Common Stock of the Issuer (see Item 4(a))
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES [ ]
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
8.5% (See Item 4(a))
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON
CO
--------------------------------------------------------------------------------
Page 5 of 16 Pages
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Bruce Bernstein
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP (a) [ ]
(b) [ ] (See Item 6)
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION: United States of America
--------------------------------------------------------------------------------
5. SOLE VOTING POWER
NUMBER OF SHARES None.
BENEFICIALLY OWNED BY 6. SHARED VOTING POWER
EACH None.
REPORTING 7. SOLE DISPOSITIVE POWER
PERSON WITH None.
8. SHARED DISPOSITIVE POWER
250,701 shares of Common Stock of the Issuer (see Item 4(a))
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
250,701 shares of Common Stock of the Issuer (see Item 4(a))
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES [ ]
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
8.5% (See Item 4(a))
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON
IN
--------------------------------------------------------------------------------
Page 6 of 16 Pages
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Olivier Morali
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP (a) [ ]
(b) [ ] (See Item 6)
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION: France
--------------------------------------------------------------------------------
5. SOLE VOTING POWER
NUMBER OF SHARES None.
BENEFICIALLY OWNED BY 6. SHARED VOTING POWER
EACH None.
REPORTING 7. SOLE DISPOSITIVE POWER
PERSON WITH None.
8. SHARED DISPOSITIVE POWER
250,701 shares of Common Stock of the Issuer (see Item 4(a))
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
250,701 shares of Common Stock of the Issuer (see Item 4(a))
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES [ ]
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
8.5% (See Item 4(a))
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON
IN
--------------------------------------------------------------------------------
Page 7 of 16 Pages
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Winchester Global Trust Company Limited
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP (a) [ ]
(b) [ ] (See Item 6)
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION: Bermuda
--------------------------------------------------------------------------------
5. SOLE VOTING POWER
NUMBER OF SHARES None.
BENEFICIALLY OWNED BY 6. SHARED VOTING POWER
EACH 250,701 shares of Common Stock of the Issuer (see Item 4(a))
REPORTING 7. SOLE DISPOSITIVE POWER
PERSON WITH None.
8. SHARED DISPOSITIVE POWER
250,701 shares of Common Stock of the Issuer (see Item 4(a))
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
250,701 shares of Common Stock of the Issuer (see Item 4(a))
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES [ ]
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
8.5% (See Item 4(a))
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON
CO
--------------------------------------------------------------------------------
Page 8 of 16 Pages
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Oskar P. Lewnowski
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP (a) [ ]
(b) [ ] (See Item 6)
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION: Austria
--------------------------------------------------------------------------------
5. SOLE VOTING POWER
NUMBER OF SHARES None.
BENEFICIALLY OWNED BY 6. SHARED VOTING POWER
EACH 250,701 shares of Common Stock of the Issuer (see Item 4(a))
REPORTING 7. SOLE DISPOSITIVE POWER
PERSON WITH None.
8. SHARED DISPOSITIVE POWER
250,701 shares of Common Stock of the Issuer (see Item 4(a))
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
250,701 shares of Common Stock of the Issuer (see Item 4(a))
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES [ ]
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
8.5% (See Item 4(a))
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON
IN
--------------------------------------------------------------------------------
ITEM 1(a). NAME OF REPORTING PERSON
Spectrum Pharmaceuticals, Inc. (the "Issuer")
ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES.
157 Technology Drive
Irvine, CA 92618
ITEM 2(a). NAMES OF PERSON FILING.
Omicron Master Trust ("Omicron Trust")
Omicron Capital, L.P. ("Omicron Capital")
Omicron Capital, Inc. ("OCI")
Bruce Bernstein ("Bernstein")
Olivier Morali ("Morali")
Winchester Global Trust Company Limited ("WGTCL")
Oskar P. Lewnowski ("Lewnowski")
Page 9 of 16 Pages
ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE, OR IF NONE, RESIDENCE.
THE ADDRESS OF THE PRINCIPAL BUSINESS OFFICE IS:
Omicron Trust - c/o Olympia Capital International Inc., Williams
House, 20 Reid Street, Hamilton HM11, Bermuda
Omicron Capital - 153 E. 53rd Street, 48th Floor, New York, New
York 10022
OCI - 153 E. 53rd Street, 48th Floor, New York, New York 10022
Bernstein - 153 E. 53rd Street, 48th Floor, New York, New York
10022
Morali - 153 E. 53rd Street, 48th Floor, New York, New York 10022
WGTCL - c/o Winchester Fiduciary Limited, Williams House, 20 Reid
Street, Hamilton HM11, Bermuda
Lewnowski - c/o Winchester Fiduciary Limited, Williams House, 20
Reid Street, Hamilton HM11, Bermuda
ITEM 2(c). CITIZENSHIP.
Omicron Trust - Bermuda
Omicron Capital - Delaware
OCI - Delaware
Bernstein - United States of America
Morali - France
WGTCL - Bermuda
Lewnowski - Austria
ITEM 2(d). TITLE OF CLASS OF SECURITIES.
Common Stock, $0.01 par value per share of the Issuer (the
"Common Stock")
ITEM 2(e). CUSIP NUMBER.
640656104
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13D-1(B) OR
13D-2(B), CHECK WHETHER THE PERSON FILING IS A:
This statement is filed pursuant to Rule 13d-1(c) by Omicron
Trust, Omicron Capital, OCI, Bernstein, Morali, WGTCL and
Lewnowski.
Page 10 of 16 Pages
ITEM 4. OWNERSHIP.
(a) Amount Beneficially Owned:
Omicron Trust: 250,701 shares*
Omicron Capital: 250,701 shares*
OCI: 250,701 shares*
Morali: 250,701 shares*
Bernstein: 250,701 shares
WGTCL: 250,701 shares*
Lewnowksi: 250,701 shares*
(b) Percent of Class:
Omicron Partners: 8.5%
Omicron Capital: 8.5%
OCI: 8.5%
Bernstein: 8.5%
Morali: 8.5%
WGTCL: 8.5%
Lewnowski: 8.5%
(based on 2,948,242 shares of Common Stock of the Issuer issued
and outstanding as January 17, 2003 as stated in the Issuer's
prospectus supplement on form 424(b)(3) dated January 29, 2003)
(c) Number of Shares as to which the Person has:
Omicron Trust, WGTCL and Lewnowski:
----------------------------------
(i) sole power to vote or to direct the vote:
none
(ii) shared power to vote or to direct the vote:
250,701 shares of Common Stock:*
(iii) sole power to dispose or to direct the
disposition of:
none
(iv) shared power to dispose or to direct the
disposition of:
250,701 shares of Common Stock*
Omicron Capital, OCI, Bernstein and Morali:
------------------------------------------
(i) sole power to vote or to direct
the vote:
none
Page 11 of 16 Pages
(ii) shared power to vote or to direct the vote:
none
(iii) sole power to dispose or to direct the
disposition of:
none
(iv) shared power to dispose or to direct the
disposition of:
250,701 shares of Common Stock*
*Omicron Capital serves as investment manager to Omicron Trust. By reason of
such relationship, Omicron Capital may be deemed to share dispositive power over
the shares of Common Stock owned by Omicron Partners. Omicron Trust disclaims
beneficial ownership of the shares of Common Stock listed as beneficially owned
by Omicron Trust or any other person reporting on this Schedule.
OCI serves as general partner of Omicron Capital. By reason of such
relationship, OCI may be deemed to share dispositive power over the shares of
Common Stock listed as beneficially owned by Omicron Capital. OCI disclaims
beneficial ownership of the shares of Common Stock listed as beneficially owned
by Omicron Capital or any other person reporting on this Schedule.
Morali serves as president and a director and is a stockholder of OCI. By
reason of such relationships, Morali may be deemed to share dispositive power
over the shares of Common Stock listed as beneficially owned by OCI. Morali
disclaims beneficial ownership of the shares of Common Stock listed as
beneficially owned by OCI or any other person reporting on this Schedule.
Bernstein serves as an officer of OCI. By reason of such relationships,
Bernstein may be deemed to share dispositive power over the shares of Common
Stock listed as beneficially owned by OCI. Bernstein disclaims beneficial
ownership of the shares of Common Stock listed as beneficially owned by OCI or
any other person reporting on this Schedule.
WGTCL serves as trustee of Omicron Trust. By reason of such relationship, WGTCL
may be deemed to shares voting and dispositive power over the shares of Common
Stock listed as beneficially owned by Omicron Trust. WGTCL disclaims
beneficial ownership of the shares of Common Stock listed as beneficially owned
by Omicron Trust or any other person reporting on this Schedule.
WGTCL may be deemed to be controlled by Lewnowski. By reason of such control,
Lewnowski may be deemed to share voting and dispositive power over the shares of
Common Stock listed as beneficially owned by WGTCL. Lewnowski disclaims
beneficial ownership of the shares of Common Stock listed as beneficially owned
by WGTCL.
Certain of the shares of Common Stock reported as beneficially owned are shares
that Omicron Trust has the right to acquire upon exercise of warrants to
purchase Common Stock held by Omicron Trust. Omicron Capital, OCI, Bernstein,
Morali, WGTCL and Lewnowski each disclaims beneficial ownership of such shares
of Common Stock.
Page 12 of 16 Pages
Of the shares of Common Stock reported as beneficially owned, 77,572 shares of
Common Stock are shares which Omicron Trust has the right to acquire upon
exercise of warrants of the Issuer.
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
Not applicable.
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
Not applicable.
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.
Not applicable.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
Not applicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP.
Not applicable.
ITEM 10. CERTIFICATION.
By signing below, I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and
are not held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were
not acquired and are not held in connection with or as a
participant in any transaction which could have that purpose or
effect.
EXHIBITS: Exhibit I: Joint Filing Agreement, dated as of February 7, 2003,
by and among Omicron Trust, Omicron Capital, OCI, Bernstein,
Morali, WGTCL and Lewnowski.
Page 13 of 16 Pages
SIGNATURE
By signing below each signatory certifies that, to the best of its
knowledge and belief, the securities referred to above were not acquired and are
not held for the purpose of or with the effect of changing or influencing the
control of the issuer of the securities and were not acquired and are not held
in connection with or as a participant in any transaction having that purpose or
effect.
Date: February 7, 2003
OMICRON MASTER TRUST
By: OMICRON CAPITAL, L.P., Investment Manager
By: OMICRON CAPITAL, INC., General Partner
By: /s/ Bruce Bernstein
----------------------------
Bruce Bernstein, President
OMICRON CAPITAL, L.P.
By: OMICRON CAPITAL, INC., General Partner
By: /s/ Bruce Bernstein
----------------------------
Bruce Bernstein, President
OMICRON CAPITAL, INC.
By: /s/ Bruce Bernstein
----------------------------
Bruce Bernstein, President
/s/ Bruce Bernstein
----------------------------
Bruce Bernstein
/s/ Olivier Morali
----------------------------
Olivier Morali
Page 14 of 16 Pages
WINCHESTER GLOBAL TRUST COMPANY LIMITED
By: /s/ Oskar P. Lewnowksi
----------------------------
Oskar P. Lewnowski, Chairman
/s/ Oskar P. Lewnowksi
---------------------------
Oskar P. Lewnowski
Page 15 of 16 Pages
Exhibit I
JOINT FILING AGREEMENT
This will confirm the agreement by and among the undersigned that the
amendment to Schedule 13G filed with the Securities and Exchange Commission on
or about the date hereof with respect to the beneficial ownership by the
undersigned of the Common Stock, $.01 par value, of Spectrum Pharmaceuticals, a
Delaware corporation, is being filed, and all amendments thereto will be filed,
on behalf of each of the persons and entities named below in accordance with
Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This
Agreement may be executed in two or more counterparts, each of which shall be
deemed an original, but all of which together shall constitute one and the same
instrument.
Dated as of February 7, 2003
OMICRON MASTER TRUST
By: OMICRON CAPITAL, L.P., Investment Manager
By: OMICRON CAPITAL, INC., General Partner
By: /s/ Bruce Bernstein
----------------------------
Bruce Bernstein, President
OMICRON CAPITAL, L.P.
By: OMICRON CAPITAL, INC., General Partner
By: /s/ Bruce Bernstein
----------------------------
Bruce Bernstein, President
OMICRON CAPITAL, INC.
By: /s/ Bruce Bernstein
----------------------------
Bruce Bernstein, President
/s/ Bruce Bernstein
----------------------------
Bruce Bernstein
/s/ Olivier Morali
----------------------------
Olivier Morali
Page 16 of 16 Pages
WINCHESTER GLOBAL TRUST COMPANY LIMITED
By: /s/ Oskar P. Lewnowksi
----------------------------
Oskar P. Lewnowski, Chairman
/s/ Oskar P. Lewnowksi
----------------------------
Oskar P. Lewnowski